Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Advanced Solid Tumor Clinical Trial
M6620 First in Human Study
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
San Antonio, TX
Click here to add this to my saved trials
Advanced Solid Tumor Clinical Trial
M6620 First in Human Study
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Vancouver, WA
Click here to add this to my saved trials
AIDS Dementia Complex Clinical Trial
Maraviroc and NeuroAIDS Pathogenesis
Status: Enrolling, Phase II, III
Updated: 1/24/2018
mi
from
San Juan,
Click here to add this to my saved trials
Symptomatic Uterine Fibroids Clinical Trial
Post Market TRUST - U.S.A. Study
Status: Enrolling
Updated: 12/31/1969
mi
from
Falls Church, VA
Click here to add this to my saved trials
Symptomatic Uterine Fibroids Clinical Trial
Post Market TRUST - U.S.A. Study
Status: Enrolling
Updated: 12/31/1969
mi
from
West Bloomfield, MI
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors (Study #1)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Ciudad Autonoma Buenos Aires,
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors (Study #1)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
San Antonio, TX
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors (Study #1)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Tyler, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB or Stage IIIB-IVB Hodgkin Lymphoma
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Downey, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB or Stage IIIB-IVB Hodgkin Lymphoma
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Gainesville, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB or Stage IIIB-IVB Hodgkin Lymphoma
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Green Bay, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB or Stage IIIB-IVB Hodgkin Lymphoma
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Oncology Clinical Trial
Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB or Stage IIIB-IVB Hodgkin Lymphoma
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Mineola, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB or Stage IIIB-IVB Hodgkin Lymphoma
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors (Study #2)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors (Study #2)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Ciudad Autonoma de Buenos Aires,
Click here to add this to my saved trials
Oncology Clinical Trial
Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Downey, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Gainesville, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Oncology Clinical Trial
Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Mineola, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
'Ewa Beach, HI
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Brighton, MI
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Caldwell, ID
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Canton, MI
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Clarkston, MI
Click here to add this to my saved trials
Neurology Clinical Trial
Efficacy and Safety of Amantadine HCl Extended Release Tablets in Parkinson's Disease Subjects With Levodopa-Induced Dyskinesias
Status: Enrolling, Phase III
Updated: 2/9/2016
mi
from
Columbus, OH
Click here to add this to my saved trials
Neurology Clinical Trial
Efficacy and Safety of Amantadine HCl Extended Release Tablets in Parkinson's Disease Subjects With Levodopa-Induced Dyskinesias
Status: Enrolling, Phase III
Updated: 2/9/2016
mi
from
Fountain Valley, CA
Click here to add this to my saved trials
Neurology Clinical Trial
Efficacy and Safety of Amantadine HCl Extended Release Tablets in Parkinson's Disease Subjects With Levodopa-Induced Dyskinesias
Status: Enrolling, Phase III
Updated: 2/9/2016
mi
from
Lexington, KY
Click here to add this to my saved trials
Neurology Clinical Trial
Efficacy and Safety of Amantadine HCl Extended Release Tablets in Parkinson's Disease Subjects With Levodopa-Induced Dyskinesias
Status: Enrolling, Phase III
Updated: 2/9/2016
mi
from
Raleigh, NC
Click here to add this to my saved trials
Neurology Clinical Trial
Efficacy and Safety of Amantadine HCl Extended Release Tablets in Parkinson's Disease Subjects With Levodopa-Induced Dyskinesias
Status: Enrolling, Phase III
Updated: 2/9/2016
mi
from
Sarasota, FL
Click here to add this to my saved trials
Neurology Clinical Trial
Efficacy and Safety of Amantadine HCl Extended Release Tablets to Treat Parkinson's Disease Patients With Levodopa Induced Dyskinesia.
Status: Enrolling, Phase III
Updated: 2/9/2016
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Neurology Clinical Trial
Efficacy and Safety of Amantadine HCl Extended Release Tablets to Treat Parkinson's Disease Patients With Levodopa Induced Dyskinesia.
Status: Enrolling, Phase III
Updated: 2/9/2016
mi
from
Reseda, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Anchorage, AK
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Arroyo Grande, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Bakersfield, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Charleston, WV
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Corona, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Creve Coeur, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Fargo, ND
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Harrisburg, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Kinston, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Longview, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Martinsville, VA
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Oxford, MS
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Pontiac, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Rancho Cucamonga, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Saint Joseph, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Torrington, CT
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
Waukesha, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling, Phase II, III
Updated: 12/31/1969
mi
from
York, PA
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Tampa, FL
Click here to add this to my saved trials
Non-Small Cell Lung Cancer (NSCLC) Clinical Trial
Calypso-based Deep Inspiration Breath Hold (DIBH) Radiation Treatments of Lung Cancer
Status: Enrolling
Updated: 12/31/1969
mi
from
Harrison, NY
Click here to add this to my saved trials
Non-Small Cell Lung Cancer (NSCLC) Clinical Trial
Calypso-based Deep Inspiration Breath Hold (DIBH) Radiation Treatments of Lung Cancer
Status: Enrolling
Updated: 12/31/1969
mi
from
Middletown, NJ
Click here to add this to my saved trials
Obstructive Sleep Apnea Clinical Trial
Comparative Efficacy Study of Titratable Versus Active Mandibular Advancement Splint in Sleep Apnea
Status: Enrolling
Updated: 5/1/2017
mi
from
Montreal,
Click here to add this to my saved trials
Nephrology / Urology, Other Clinical Trial
Health-related Quality of Life in Rare Kidney Stone
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Reykjavik,
Click here to add this to my saved trials
Smoking Cessation Clinical Trial
Evaluation of Deep Transcranial Magnetic Stimulation (DTMS) With the H-ADD Coil as an Aid to Smoking Cessation.
Status: Enrolling, Phase III
Updated: 1/24/2018
mi
from
New York, NY
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
OPsumit USers Registry
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
OPsumit USers Registry
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
OPsumit USers Registry
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Columbus, OH
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
OPsumit USers Registry
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Detroit, MI
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
OPsumit USers Registry
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Falls Church, VA
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
OPsumit USers Registry
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Henderson, NV
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
OPsumit USers Registry
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Hudson, FL
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
OPsumit USers Registry
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
OPsumit USers Registry
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Kansas City, KS
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
OPsumit USers Registry
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
OPsumit USers Registry
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Madison, WI
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
OPsumit USers Registry
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Marietta, GA
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
OPsumit USers Registry
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Middleburg Heights, OH
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
OPsumit USers Registry
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Mobile, AL
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
OPsumit USers Registry
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Moreno Valley, CA
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
OPsumit USers Registry
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
New Haven, CT
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
OPsumit USers Registry
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
OPsumit USers Registry
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Portland, OR
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
OPsumit USers Registry
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Reno, NV
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
OPsumit USers Registry
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
San Antonio, TX
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
OPsumit USers Registry
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
South Portland, ME
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
OPsumit USers Registry
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Tampa, FL
Click here to add this to my saved trials
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease Clinical Trial
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Lynchburg, VA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study of Pembrolizumab (MK-3475) in Combination With Standard of Care Treatments in Participants With Multiple Myeloma (MK-3475-023/KEYNOTE-023)
Status: Enrolling, Phase I
Updated: 5/11/2017
mi
from
Boston, MA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study of Pembrolizumab (MK-3475) in Combination With Standard of Care Treatments in Participants With Multiple Myeloma (MK-3475-023/KEYNOTE-023)
Status: Enrolling, Phase I
Updated: 5/11/2017
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study of Pembrolizumab (MK-3475) in Combination With Standard of Care Treatments in Participants With Multiple Myeloma (MK-3475-023/KEYNOTE-023)
Status: Enrolling, Phase I
Updated: 5/11/2017
mi
from
Houston, TX
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study of Pembrolizumab (MK-3475) in Combination With Standard of Care Treatments in Participants With Multiple Myeloma (MK-3475-023/KEYNOTE-023)
Status: Enrolling, Phase I
Updated: 5/11/2017
mi
from
Kirkland,
Click here to add this to my saved trials
Pulmonary Arterial Hypertension Clinical Trial
Effects of Oral Sildenafil on Mortality in Adults With PAH
Status: Enrolling, Phase IV
Updated: 12/31/1969
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Great Bend, KS
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Green Bay, WI
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Honolulu, HI
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
mi
from
Macomb, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Canandaigua, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Canton, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Carterville, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Chelsea, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Covington, LA
Click here to add this to my saved trials
Oncology Clinical Trial
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Denver, CO
Click here to add this to my saved trials
Oncology Clinical Trial
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Grosse Pointe Woods, MI
Click here to add this to my saved trials